• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Catalog Number 442963
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/09/2023
Event Type  malfunction  
Manufacturer Narrative
E.1.(b)(6).H.3.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
2 of 2.It was reported that patient samples tested with the bd max¿ enteric bacterial panel gave false negative results for salmonella and campylobacter.Samples were not reported out so there was no patient impact.Confirmatory tests were performed: sample 2: positive antigen test.
 
Manufacturer Narrative
H6.Investigation summary: the complaint investigation for discrepant results when using the bd max¿ enteric bacterial panel assay (ref.(b)(4)) from lot 3172498 was performed by the review of the manufacturing records, retain material testing, review of customer¿s data and by the complaint¿s history review.Review of the manufacturing records of bd max¿ enteric bacterial panel assay indicated that lot 3172498 was manufactured according to specifications and met performance requirements.The retain material of bd max¿ enteric bacterial panel (ebp) assay from lot 3172498 was tested and the results were as expected, without any anomaly.The reagents performed within specifications.Customer complained about discrepancies for two distinct samples when compared with alternate methods.A first sample received a negative result for salmonella target but tested positive by conventional culture while a second sample received a negative result for campylobacter target but resulted in a positive with an antigen test.Customer provided no further information concerning the specific samples involved in the issue, and specific analysis could not be performed.However, customer provided the database from instrument ct0543 for investigation.Manual pcr curve adjudication was conducted across all samples tested with bd max¿ ebp assay kit lot #3172498.Analysis of pcr curves of all samples showed no sign of pcr amplification for any ebp targets, and a strong amplification of internal control (cy5.5 channel), resulting in negative results, without anomaly.Based on this curves analysis, no reagents issue for any of the samples is suspected.According to this data and considering the fact the retain material testing showed that kit lot #3172498 still performs as expected, no reagents issue is suspected.Overall, based on the investigation and available information, the root cause was not identified.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on the bd max¿ enteric bacterial panel assay lot 3172498.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa) since no new hazard was identified.Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.H3 other text : see h10.
 
Event Description
2 of 2 it was reported that patient samples tested with the bd max¿ enteric bacterial panel gave false negative results for salmonella and campylobacter.Samples were not reported out so there was no patient impact.Confirmatory tests were performed: sample 2: positive antigen test.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ ENTERIC BACTERIAL PANEL
Type of Device
GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18275221
MDR Text Key329841982
Report Number3007420875-2023-00117
Device Sequence Number1
Product Code PCI
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K140111
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number442963
Device Lot Number3172498
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/31/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/21/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-